Spots Global Cancer Trial Database for ewing's sarcoma
Every month we try and update this database with for ewing's sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy | NCT01674101 | Osteosarcoma Ewing's Sarcoma Rhabdomyosarcom... Synovial Sarcom... Malignant Perip... Malignant Fibro... Chondrosarcoma ... | Endurance Strengthening Stretching Home exercise p... | 6 Years - 30 Years | St. Jude Children's Research Hospital | |
| Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma | NCT01583543 | Ewing's Sarcoma | Olaparib | 18 Years - | Massachusetts General Hospital | |
| New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma | NCT00001335 | Ewing's Sarcoma Neuroblastoma Rhabdomyosarcom... | ADR-529 Topotecan G-CSF | - | National Institutes of Health Clinical Center (CC) | |
| Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas | NCT00043979 | Sarcoma | F-18 Fluorodeox... therapeutic all... cyclophosphamid... cyclosporine doxorubicin hyd... etoposide fludarabine pho... melphalan prednisone sirolimus tacrolimus vincristine sul... peripheral bloo... Filgrastim Peripheral Bloo... | 5 Years - 35 Years | National Institutes of Health Clinical Center (CC) | |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors | NCT00179816 | Ewing's Sarcoma Soft Tissue Sar... Hepatoblastoma Hodgkin's Disea... Germ Cell Tumor | High-Dose Chemo... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features | NCT00314925 | Carcinoid Neuroendocrine | Seneca Valley V... | 18 Years - | Neotropix | |
| HGS-ETR2 to Treat Children With Solid Tumors | NCT00428272 | Ewing's Sarcoma Osteosarcoma Neuroblastoma Rhabdomyosarcom... | Lexatumumab alo... Lexatumumab in ... Interferon gamm... Gamma 1b potent... | 1 Year - 30 Years | National Institutes of Health Clinical Center (CC) | |
| Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI | NCT01336803 | Bone Cancer Chondrosarcoma Ewing's Sarcoma Osteosarcoma Rhabdomyosarcom... Bone Necrosis Bone Sarcoma Osteomyelitis | Feraheme Magnetic Resona... | 10 Years - 21 Years | Stanford University | |
| Phase II Pilot Study of Vincristine, Adriamycin, Actinomycin D, Ifosfamide Combination Chemotherapy in Ewing's Sarcoma | NCT00541411 | Ewing's Sarcoma | Vincristine, Ac... | - | King Faisal Specialist Hospital & Research Center | |
| A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma | NCT04238819 | Relapsed Solid ... Refractory Soli... | Abemaciclib Irinotecan Temozolomide Dinutuximab GM-CSF | - 21 Years | Eli Lilly and Company | |
| Study in Localized and Disseminated Ewing Sarcoma | NCT00987636 | Ewing's Sarcoma | Zoledronic acid Busulfan Treosulfan | 48 Months - 50 Years | University Hospital Muenster | |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors | NCT02076906 | Relapsed Pediat... Refractory Pedi... Rhabdomyosarcom... Ewing Sarcoma Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor Desmoid Tumor | Magnetic Resona... | - 30 Years | Children's National Research Institute | |
| Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma | NCT02063022 | Ewing's Sarcoma | Standard treatm... Intensified che... | - 40 Years | Italian Sarcoma Group | |
| Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma | NCT00949325 | Sarcoma | temsirolimus pl... | 1 Year - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma | NCT01313884 | Bone Cancer Ewing's Sarcoma | Irinotecan Vincristine Temozolomide Doxorubicin Cytoxan Pegfilgrastim | 13 Years - | Stanford University | |
| Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma | NCT01583543 | Ewing's Sarcoma | Olaparib | 18 Years - | Massachusetts General Hospital | |
| Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy | NCT01222767 | Ewing's Sarcoma Primitive Neuro... Askin's Tumor o... Extraosseous Ew... | Zalypsis | 16 Years - | PharmaMar | |
| Effects of Preoperative Physical Therapy in Patients With Lower Extremity Malignancy | NCT01674101 | Osteosarcoma Ewing's Sarcoma Rhabdomyosarcom... Synovial Sarcom... Malignant Perip... Malignant Fibro... Chondrosarcoma ... | Endurance Strengthening Stretching Home exercise p... | 6 Years - 30 Years | St. Jude Children's Research Hospital | |
| Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy | NCT01222767 | Ewing's Sarcoma Primitive Neuro... Askin's Tumor o... Extraosseous Ew... | Zalypsis | 16 Years - | PharmaMar | |
| A Two-part Phase IIb Trial of Vigil (Bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in Ewing's Sarcoma | NCT02511132 | Ewing's Sarcoma | Vigil Temozolomide Irinotecan Gemcitabine Docetaxel | 2 Years - | Gradalis, Inc. | |
| Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features | NCT00314925 | Carcinoid Neuroendocrine | Seneca Valley V... | 18 Years - | Neotropix | |
| Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma | NCT01583543 | Ewing's Sarcoma | Olaparib | 18 Years - | Massachusetts General Hospital | |
| A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas | NCT00001564 | Ewing's Sarcoma Rhabdomyosarcom... | EF-1 Peptide EF-2 Peptide PXFK Peptide E7 Peptide IL-2 IL-4 GM-CSF CD40 Ligand | - 30 Years | National Institutes of Health Clinical Center (CC) | |
| Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas | NCT03442465 | Bone Sarcoma Osteosarcoma Chondrosarcoma Ewing's Sarcoma Osseous Sarcoma Bone Neoplasm | Toronto Extremi... Musculoskeletal... Timed Get Up an... Orthogonal Radi... Weight Bearing ... Range of Motion | 4 Years - | Memorial Sloan Kettering Cancer Center | |
| New Therapeutic Strategies for Patients With Ewing's Sarcoma Family of Tumors, High Risk Rhabdomyosarcoma, and Neuroblastoma | NCT00001335 | Ewing's Sarcoma Neuroblastoma Rhabdomyosarcom... | ADR-529 Topotecan G-CSF | - | National Institutes of Health Clinical Center (CC) | |
| A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. | NCT04671693 | Late Effects Testicular Germ... Non-Metastatic ... Soft Tissue Sar... Osteosarcoma Ewing's Sarcoma Acute Myeloid L... Hodgkin Disease Non Hodgkin Lym... | PASCA intervent... | 18 Years - 65 Years | Centre Leon Berard | |
| Efficacy of Dose Intensification in Patients With Non-metastatic Ewing Sarcoma | NCT02063022 | Ewing's Sarcoma | Standard treatm... Intensified che... | - 40 Years | Italian Sarcoma Group | |
| Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803 | NCT02890758 | Acute Myeloid L... Myelodysplastic... Acute Lymphobla... Chronic Myeloid... Chronic Lymphoc... Non Hodgkin Lym... Hodgkin Lymphom... Myeloproliferat... Plasma Cell Mye... Colon Carcinoma Adenocarcinoma ... Soft Tissue Sar... Ewing's Sarcoma Rhabdomyosarcom... | Natural Killer ... ALT803 | 18 Years - | Case Comprehensive Cancer Center | |
| Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors | NCT02574728 | Cancer | Sirolimus Celecoxib Etoposide Cyclophosphamid... | 12 Months - 30 Years | Emory University | |
| Study in Localized and Disseminated Ewing Sarcoma | NCT00987636 | Ewing's Sarcoma | Zoledronic acid Busulfan Treosulfan | 48 Months - 50 Years | University Hospital Muenster | |
| Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma | NCT05734066 | Refractory Ewin... Relapsed Ewing ... Ewing Sarcoma | Lurbinectedin | 2 Years - 30 Years | Jazz Pharmaceuticals | |
| Aerosol L9-NC and Temozolomide in Ewing's Sarcoma | NCT00492141 | Ewing's Sarcoma | Temozolomide L9-NC | 10 Years - | M.D. Anderson Cancer Center | |
| Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults | NCT01696669 | Ewing's Sarcoma | Chemotherapy Surgery Radiotherapy | - 40 Years | Grupo Espanol de Investigacion en Sarcomas | |
| Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors | NCT00179816 | Ewing's Sarcoma Soft Tissue Sar... Hepatoblastoma Hodgkin's Disea... Germ Cell Tumor | High-Dose Chemo... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Blood and Tissue Study of Patients in NIH Protocol 08-C-0800 | NCT00923325 | Sarcomas | 2 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas | NCT00001566 | Ewing's Sarcoma Rhabdomyosarcom... | therapeutic aut... indinavir sulfa... peripheral bloo... | 5 Years - 35 Years | National Institutes of Health Clinical Center (CC) | |
| Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas | NCT05131386 | Soft Tissue Sar... Bone Tumors Small Round-cel... | Trabectedin | 16 Years - 75 Years | Grupo Espanol de Investigacion en Sarcomas | |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients | NCT00038142 | Ewing's Sarcoma | Vincristine Doxorubicin Cyclophosphamid... Dexrazoxane ImmTher | 3 Years - 60 Years | M.D. Anderson Cancer Center | |
| Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults | NCT01696669 | Ewing's Sarcoma | Chemotherapy Surgery Radiotherapy | - 40 Years | Grupo Espanol de Investigacion en Sarcomas | |
| Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors | NCT02689336 | Glioma Rhabdomyosarcom... Osteosarcoma Medulloblastoma Neuroectodermal... Ependymoma Ewing's Sarcoma Wilms Tumor | Erlotinib Temozolomide | 1 Year - 21 Years | Washington University School of Medicine | |
| Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients | NCT01169584 | Neuroblastoma Rhabdomyosarcom... Lymphoma Wilm's Tumor Ewing's Sarcoma | Recombinant Vac... | 2 Years - 21 Years | SillaJen, Inc. | |
| Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma | NCT00949325 | Sarcoma | temsirolimus pl... | 1 Year - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients | NCT00038142 | Ewing's Sarcoma | Vincristine Doxorubicin Cyclophosphamid... Dexrazoxane ImmTher | 3 Years - 60 Years | M.D. Anderson Cancer Center | |
| Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas | NCT05131386 | Soft Tissue Sar... Bone Tumors Small Round-cel... | Trabectedin | 16 Years - 75 Years | Grupo Espanol de Investigacion en Sarcomas | |
| Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients | NCT01169584 | Neuroblastoma Rhabdomyosarcom... Lymphoma Wilm's Tumor Ewing's Sarcoma | Recombinant Vac... | 2 Years - 21 Years | SillaJen, Inc. | |
| Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors | NCT02689336 | Glioma Rhabdomyosarcom... Osteosarcoma Medulloblastoma Neuroectodermal... Ependymoma Ewing's Sarcoma Wilms Tumor | Erlotinib Temozolomide | 1 Year - 21 Years | Washington University School of Medicine | |
| Post-operative Radiotherapy in Poor Responders Ewing's Sarcoma Patients | NCT01734863 | Ewing's Sarcoma | External Beam R... | 1 Year - 18 Years | Children's Cancer Hospital Egypt 57357 | |
| MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors | NCT02076906 | Relapsed Pediat... Refractory Pedi... Rhabdomyosarcom... Ewing Sarcoma Osteosarcoma Neuroblastoma Wilms Tumor Hepatic Tumor Germ Cell Tumor Desmoid Tumor | Magnetic Resona... | - 30 Years | Children's National Research Institute | |
| Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases | NCT00001686 | Ewing's Sarcoma Leukemia Lymphoma Brain Tumors Rhabdomyosarcom... | 2 Years - 40 Years | National Institutes of Health Clinical Center (CC) | ||
| Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides | NCT01598454 | Neuroblastoma Ewing's Sarcoma Wilm's Tumor Retinoblastoma Glioma | racotumomab | 1 Year - 10 Years | Laboratorio Elea Phoenix S.A. | |
| Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases | NCT00001686 | Ewing's Sarcoma Leukemia Lymphoma Brain Tumors Rhabdomyosarcom... | 2 Years - 40 Years | National Institutes of Health Clinical Center (CC) | ||
| QUILT-3.025: A Phase 2 Study of AMG 479 in Relapsed or Refractory Ewing's Family Tumor and Desmoplastic Small Round Cell Tumors | NCT00563680 | Askin's Tumors Desmoplastic Sm... Estraosseous Ew... Ewing's Family ... Ewing's Sarcoma Primitive Neuro... Sarcoma | AMG 479 | 16 Years - | NantCell, Inc. | |
| Blood and Tissue Study of Patients in NIH Protocol 08-C-0800 | NCT00923325 | Sarcomas | 2 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma | NCT01492673 | Neuroblastoma Sarcoma | Cyclophosphamid... | - 21 Years | Memorial Sloan Kettering Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
